To mark its 20th year of publication, The American Journal of Managed Care has invited guest contributors to comment on the state of healthcare from their perspective. This month, Karen Ignagni, MBA, president and CEO of America's Health Insurance Plans and consistently rated as one of healthcare's most important voices, writes how health plans are supporting value-based care and promoting consumer choice.
Health Plans Drive Innovation, With More to ComeFOR IMMEDIATE RELEASEMarch 31, 2015
PLAINSBORO, N.J.—The nation’s health plans support the movement toward value-based payment, and they are doing so in a number of ways that are helping consumers, writes the head of the nation’s largest association of health insurance plans in this month’s issue of The American Journal of Managed Care (AJMC).
With “Innovation in Plain Sight,” Karen Ignagni, MBA, president and CEO of America’s Health Insurance Plans (AHIP), is the latest contributor in AJMC’s series to mark its 20th year of publication. Ignagni’s essay comes shortly after AHIP announced its support for historic value-based payment goals set forth by the US Department of Health and Human Services (HHS), which call for 50% of Medicare reimbursement to be value-based by 2018.
In her essay, Ignagni outlines the many ways that health plans are driving the movement toward better healthcare delivery, including:
Ignagni warns against steps by some states to require health plans to include specialty hospitals in their “high-value networks,” no matter what they cost. Limiting providers in these networks, she wrote, has resulted in premium savings for consumers. Ignagni also discusses the ongoing challenge of rising prescription drug costs. “Patients are experiencing take-it-or-leave-it pricing that jeopardizes access to the medications they need,” she writes.
To read the full essay, click here.
About the Journals
The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
CONTACT: Nicole Beagin (609) 716-7777 x 131
nbeagin@ajmc.com
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
October 22nd 2024This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More